{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:34:02Z","timestamp":1769150042756,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cmi.2023.04.004","type":"journal-article","created":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T09:37:22Z","timestamp":1681033042000},"page":"955-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia"],"prefix":"10.1016","volume":"29","author":[{"given":"Ahmad","family":"Mourad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Vance G.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.04.004_bib1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cmi.2022.10.008","article-title":"Which randomized controlled trial do we need?","volume":"28","author":"Leibovici","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.04.004_bib2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.04.004_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.cmi.2020.01.003","article-title":"Duration of antibiotic therapy for Staphylococcus aureus bacteraemia: the long and the short of it","volume":"26","author":"Eichenberger","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.04.004_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cid\/ciy774","article-title":"Considerations for clinical trials of Staphylococcus aureus bloodstream infection in adults","volume":"68","author":"Holland","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.004_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/jiac219","article-title":"Heterogeneity in Staphylococcus aureus bacteraemia clinical trials complicates interpretation of findings","volume":"226","author":"Dolby","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.004_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2023.04.004_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/fmb-2019-0332","article-title":"Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, phase III trial","volume":"15","author":"Hamed","year":"2020","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cmi.2023.04.004_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cmi.2023.04.004_bib9","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/cid\/ciab742","volume":"74","author":"Eichenberger","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.004_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac426","article-title":"Microbial cell-free DNA identifies the causative pathogen in infective endocarditis and remains detectable longer than conventional blood culture in patients with prior antibiotic therapy","volume":"76","author":"Eichenberger","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.004_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/ciw788","article-title":"MASTERMIND: bringing microbial diagnostics to the clinic","volume":"64","author":"Patel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.004_bib12","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.004_bib13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/cid\/ciy766","article-title":"Good studies evaluate the disease while great studies evaluate the patient: development and application of a desirability of outcome ranking endpoint for Staphylococcus aureus bloodstream infection","volume":"68","author":"Doernberg","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.004_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR)","volume":"61","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:35:58Z","timestamp":1761118558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1198743X23001581"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.04.004","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}